Peptidic nanoparticles for cancer therapy and diagnosis

2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings

Volumn , Issue , 2005, Pages 112-115

  Graff, A ^a   Tropel, D ^a   Raman, S K ^a   Machaidze, G ^a   Lustig, A ^a   Burkhard, P ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Cancer targeting; Drug delivery; Drug targeting; Peptide nanoparticles; Self assembly

Indexed keywords

DIAGNOSIS; DRUG PRODUCTS; ONCOLOGY; POLYPEPTIDES; SELF ASSEMBLY; TOXICITY;

CANCER TARGETING; DRUG DELIVERY; DRUG TARGETING; PEPTIDE NANOPARTICLES;

NANOSTRUCTURED MATERIALS;

EID: 32044467558     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (17)

1. Burkhard, P. (2004). PCT patent application, WO 2004/071493.
2. Serafini, A. N., From monoclonal antibodies to peptides and molecular recognition units: an overview, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 34 (3 Suppl), 533-536, 1993.
3. Fischman, A. J., Babich J. W., Strauss, H. W., A ticket to ride: peptide radiopharmaceuticals, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 34(12), 2253-63, 1993.
4. Thakur, M. L., Radiolabelied peptides: now and the future, Nuclear medicine communications, 16(9), 724-32, 1995.
5. Scarpignato, C., Pelosini, I., Somatostatin analogs for cancer treatment and diagnosis: an overview. Chemotherapy (Basel, Switzerland), 47 (Suppl.2), 1-29, 2001.
6. Blok, D., Feitsma, R. I. J., Vermeij, P., Pauwels, E. J. K., Peptide radiopharmaceuticals in nuclear medicine. European Journal of Nuclear Medicine, 26(11), 1511-1519, 1999.
7. Zhang, Y.P., Ceh, B., Lasic, D. D., Liposomes in drug delivery. Polymeric Biomaterials (2nd Edition), 783-821, 2002.
8. Papahadjopoulos, D., Gabizon, A., Targeting of liposomes to tumor cells in vivo, Annals of the New York Academy of Sciences, 507 (Biol. Approaches Controlled Delivery Drugs), 64-74, 1987.
9. Lasic, D.D., Stealth liposomes, Drugs and the Pharmaceutical Sciences, 73 (Microencapsulation), 297-328, 1996.
10. Malshkevich, V. N., Kammerer, R. A., Efimov, V. P., Schulthess, T. and Engel, J. The crystal structure of a five-stranded coiled-coil in COMP: a prototype ion channel? Science 274, 761-765, 1996.
11. Johnson, J. E. and Reddy, V. S. Biggest virus molecular structure yet! Nature Structural Biology, 5, 849-854, 1998.
12. Burkhard, P., Ivaninskii, S., Lustig, A., Improving coiled-coil stability by optimizing ionic interactions, Journal of Molecular Biology, 318(3), 901-910, 2002.
13. Burkhard, P., Meier, M., Lustig, A., Design of a minimal protein oligomerization domain by a structural approach, Protein Science, 9(12), 2294-2301, 2000.
14. Van Zanten, John H. Characterization of vesicles and vesicular dispersions via scattering techniques. Surfactant Science Series (1996), 62(Vesicles), 239-294.
15. Van Zanten, J. H., Monbouquette, Harold G., Characterization of vesicles by classical light scattering, Journal of Colloid and Interface Science, 146(2), 330-6, 1991.
16. Ruf, H., Georgalis, Y., Grell, E., Dynamic laser light scattering to determine size distributions of vesicles, Methods in Enzymology, 172 (Biomembranes, Pt. S), 364-90, 1989.
17. Weidemann, T., Wachsmuth, M., Tewes, M., Rippe, K., Langowski, J., Analysis of ligand binding by two-color fluorescence cross-correlation spectroscopy, Single Molecules, 3(1), 49-61, 2002.